Biotechniques 2004, 36 (3) : 450–454.PubMed 8. Tu SP, Jiang XH, Lin MC, Cui JT, Yang Y, Lum CT, Zou B, Zhu YB, Jiang SH, Wong WM, et al.: Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis

in gastric cancer. Cancer Res 2003, 63 (22) : 7724–7732.PubMed 9. Pennati M, Colella G, Folini M, Citti L, Daidone MG, Zaffaroni N: Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced find more apoptosis. J Clin Invest 2002, 109 (2) : 285–286.PubMed 10. Pennati M, Binda M, Colella G, Zoppe M, Folini M, Vignati S, Valentini A, Citti L, De Cesare M, Pratesi G, et al.: Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Oncogene 2004, 23 (2) : 386–394.CrossRefPubMed 11. Shen C, Buck A, Polat B, Schmid-Kotsas A, Matuschek C, Gross HJ, Bachem M, Reske SN: Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells. Cancer Gene Ther 2003, 10 (5) : 403–410.CrossRefPubMed 12. Zhang M, Yang J, Li F: Transcriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment. J Exp Clin Cancer Res 2006,

25 (3) : 391–402.PubMed 13. Chun JY, Hu Y, Pinder E, Wu J, Li F, Gao AC: Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. high throughput screening compounds Mol Cancer Ther 2007, 6 (9) : 2572–2580.CrossRefPubMed 14. Li F, Altieri DC: Transcriptional analysis of human survivin gene expression. Biochem J 1999, 344 (Pt 2) : 305–311.CrossRefPubMed 15. Zhu N, Gu L, Findley HW, Chen C, Dong JT, Yang L, Zhou M: KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic Gefitinib datasheet leukemia. J Biol Chem 2006, 281 (21) : 14711–14718.CrossRefPubMed 16. Harrison L, Blackwell K: Hypoxia and anemia: factors in decreased sensitivity to radiation therapy

and chemotherapy? Oncologist 2004, 9 (Suppl 5) : 31–40.CrossRefPubMed 17. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996, 56 (19) : 4509–4515.PubMed 18. Bottaro DP, Liotta LA: Cancer: Out of air is not out of action. Nature 2003, 423 (6940) : 593–595.CrossRefPubMed 19. Chang Q, Qin R, Huang T, Gao J, Feng Y: Effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer. Pancreas 2006, 32 (3) : 297–305.CrossRefPubMed 20. Peng XH, Karna P, Cao Z, Jiang BH, Zhou M, Yang L: Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 2006, 281 (36) : 25903–25914.CrossRefPubMed 21.